Cargando…
Oral Immunization with Recombinant Lactobacillus acidophilus Expressing espA-Tir-M Confers Protection against Enterohemorrhagic Escherichia coli O157:H7 Challenge in Mice
Enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) causes hemorrhagic colitis and the formation of characteristic attaching and effacing (A/E) lesions in humans. Given the severe sequelae of EHEC O157:H7 infection, it is critical to develop effective vaccines for human use. However, for achie...
Autores principales: | Lin, Ruqin, Zhang, Yiduo, Long, Beiguo, Li, Yawen, Wu, Yuhua, Duan, Siqin, Zhu, Bo, Wu, Xianbo, Fan, Hongying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350096/ https://www.ncbi.nlm.nih.gov/pubmed/28360900 http://dx.doi.org/10.3389/fmicb.2017.00417 |
Ejemplares similares
-
In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications
por: Amani, Jafar, et al.
Publicado: (2009) -
Contributions of EspA Filaments and Curli Fimbriae in Cellular Adherence and Biofilm Formation of Enterohemorrhagic Escherichia coli O157:H7
por: Sharma, Vijay K., et al.
Publicado: (2016) -
Optimizing the Protection of Cattle against Escherichia coli O157:H7 Colonization through Immunization with Different Combinations of H7 Flagellin, Tir, Intimin-531 or EspA
por: McNeilly, Tom N., et al.
Publicado: (2015) -
EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7
por: Rad, Hamid Sedighian, et al.
Publicado: (2013) -
Two Enteropathogenic Escherichia coli Type III Secreted Proteins, EspA and EspB, Are Virulence Factors
por: Abe, Akio, et al.
Publicado: (1998)